IL-6 trans-signaling has been suggested to be involved in expression of fibroblast growth factor 23 (FGF23), which has been well documented to not only be elevated in serum of CKD patients, but also strongly associated with mortality [160]. Here, IL6 is linked to chronic kidney disease.